Search Results - "Tafur, A J"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    Cancer effect on periprocedural thromboembolism and bleeding in anticoagulated patients by Tafur, A.J., Wysokinski, W.E., McBane, R.D., Wolny, E., Sutkowska, E., Litin, S.C., Daniels, P.R., Slusser, J.P., Hodge, D.O., Heit, J.A.

    Published in Annals of oncology (01-08-2012)
    “…Patients with active cancer are often on chronic anticoagulation and frequently require interruption of this treatment for invasive procedures. The impact of…”
    Get full text
    Journal Article
  2. 2

    Prospective evaluation of protein C and factor VIII in prediction of cancer-associated thrombosis by Tafur, A.J, Dale, G, Cherry, M, Wren, J.D, Mansfield, A.S, Comp, P, Rathbun, S, Stoner, J.A

    Published in Thrombosis research (01-12-2015)
    “…Abstract Venous thromboembolism (VTE) is a preventable disease, yet it is one of the leading causes of death among patients with cancer. Improving risk…”
    Get full text
    Journal Article
  3. 3

    Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancer by Mansfield, A. S., Tafur, A. J., Wang, C. E., Kourelis, T. V., Wysokinska, E. M., Yang, P.

    Published in Journal of thrombosis and haemostasis (01-09-2016)
    “…Essentials Venous thromboembolism (VTE) prevention strategies require effective risk assessment models. We sought to validate the Khorana Risk Score (KRS) in…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Predictors of major bleeding in peri‐procedural anticoagulation management by TAFUR, A. J., McBANE, R., WYSOKINSKI, W. E., LITIN, S., DANIELS, P., SLUSSER, J., HODGE, D., BECKMAN, M. G., HEIT, J. A.

    Published in Journal of thrombosis and haemostasis (01-02-2012)
    “…Background: Appropriate periprocedural management for chronically anticoagulated patients requires assessment of patient‐specific thrombosis and bleeding…”
    Get full text
    Journal Article
  6. 6

    Meta-analysis on anticoagulation and prevention of thrombosis and mortality among patients with lung cancer by Fuentes, H.E, Oramas, D.M, Paz, L.H, Casanegra, A.I, Mansfield, A.S, Tafur, A.J

    Published in Thrombosis research (01-06-2017)
    “…Abstract Background Venous thromboembolism (Wickham et al., 2012 [1]) is a leading cause of morbidity and mortality among patients with cancer; however,…”
    Get full text
    Journal Article
  7. 7

    Venous Thromboembolism Is an Independent Predictor of Mortality Among Patients with Gastric Cancer by Fuentes, Harry E., Oramas, D. M., Paz, L. H., Wang, Y., Andrade, X. A., Tafur, A. J.

    Published in Journal of gastrointestinal cancer (01-12-2018)
    “…Background Venous thromboembolism (VTE) is an independent predictor of death among patients with cancer. Patients with gastric cancer (GC) are at higher risk…”
    Get full text
    Journal Article
  8. 8

    Performance of Khorana Risk Score for Prediction of Venous Thromboembolism in Patients With Hepatocellular Carcinoma by Wang, Y., Attar, B. M., Fuentes, H. E., Yu, J., Zhang, Huiyuan, Tafur, A. J.

    Published in Clinical and applied thrombosis/hemostasis (01-04-2018)
    “…Cancer-associated venous thromboembolism (VTE) is one of the leading causes of mortality and morbidity among patients with malignancy. The Khorana risk score…”
    Get full text
    Journal Article
  9. 9

    Performance of Current Thromboembolism Risk Assessment Tools in Patients With Gastric Cancer and Validity After First Treatment by Fuentes, Harry E., Paz, L. H., Wang, Y., Oramas, D. M., Simons, C. R., Tafur, A. J.

    Published in Clinical and applied thrombosis/hemostasis (01-07-2018)
    “…Patients with gastric cancer (GC) are at higher risk of thromboembolism when compared to other solid tumors. We aim to determine the predictive performance of…”
    Get full text
    Journal Article
  10. 10

    Characteristics and Impacts of Venous Thromboembolism in Patients with Hepatocellular Carcinoma by Wang, Yuchen, Attar, B. M., Hinami, K., Fuentes, H. E., Jaiswal, P., Zhang, H., Simons-Linares, C. S., Tafur, A. J.

    Published in Journal of gastrointestinal cancer (01-09-2018)
    “…Introduction Venous thromboembolism (VTE) is a common complication in cancer patients, and is associated with worse prognosis in such population…”
    Get full text
    Journal Article
  11. 11

    Severe hepatic dysfunction is associated with venous thromboembolic events in phase 1 clinical trials by Mansfield, A.S, Tafur, A.J, Vulih, D, Smith, G.L, Harris, P.J, Ivy, S.P

    Published in Thrombosis research (01-12-2015)
    “…Abstract Introduction Venous thromboembolic events (VTEs) are a significant cause of death in patients with cancer. The incidence of VTE is not well…”
    Get full text
    Journal Article
  12. 12

    Bone marrow toxicity after yellow phosphorus ingestion by Tafur, A J, Zapatier, J A, Idrovo, L A, Oliveros, J W, Garces, J C

    Published in Emergency medicine journal : EMJ (01-03-2004)
    “…Suicidal ingestions of fireworks containing yellow phosphorus occur often during holidays. A case is reported of a 17 year old woman who intentionally ingested…”
    Get full text
    Journal Article
  13. 13

    The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis by Mulder, Frits I, Candeloro, Matteo, Kamphuisen, Pieter W, Di Nisio, Marcello, Bossuyt, Patrick M, Guman, Noori, Smit, Kirsten, Büller, Harry R, van Es, Nick

    Published in Haematologica (Roma) (01-06-2019)
    “…We aimed to evaluate the performance of the Khorana score in predicting venous thromboembolic events in ambulatory cancer patients. Embase and MEDLINE were…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Unusual complication of an organophosphate poisoning by Tafur, A J, Gonzalez, L, Idrovo, L A, Tafur, A

    Published in Emergency medicine journal : EMJ (01-07-2005)
    “…An acute cholinergic phase followed by intermediate syndrome in organophosphate poisoning was diagnosed; 1 however, tremors, dysarthria, cogwheel rigidity, and…”
    Get full text
    Journal Article
  16. 16

    Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates From Peru, 2018 and 2019 by Jorge-Berrocal, Ana, Vargas-Herrera, Natalia, Benites, Carlos, Salazar-Quispe, Fabiola, Mayta-Barrios, Maritza, Barrios-Cárdenas, Yuli J., Melano, Roberto G., Yagui, Martin

    Published in Sexually transmitted diseases (01-10-2022)
    “…Background Currently, in Latin America, including Peru, the treatment of gonorrhea is still empiric and information regarding antimicrobial resistance is…”
    Get full text
    Journal Article
  17. 17

    Differences in galectin-3, a biomarker of fibrosis, between participants with peripheral artery disease and participants with normal ankle–brachial index by Casanegra, Ana I, Stoner, Julie A, Tafur, Alfonso J, Pereira, H Anne, Rathbun, Suman W, Gardner, Andrew W

    Published in Vascular medicine (London, England) (01-10-2016)
    “…The aim of this study was to determine if galectin-3 levels were different between participants with peripheral artery disease (PAD) and controls, and to…”
    Get full text
    Journal Article
  18. 18

    Cancer effect on periprocedural thromboembolism and bleeding in anticoagulated patients by Tafur, A J, Wysokinski, W E, McBane, R D, Wolny, E, Sutkowska, E, Litin, S C, Daniels, P R, Slusser, J P, Hodge, D O, Heit, J A

    Published in Annals of oncology (01-08-2012)
    “…Patients with active cancer are often on chronic anticoagulation and frequently require interruption of this treatment for invasive procedures. The impact of…”
    Get full text
    Journal Article